Clinical Trial Update: Safety of Dabigatran Etexilate in Blood Clot Prevention in Children [Phase 3]

View source ↗

Summary

Phase 3 trial assessing safety of dabigatran etexilate for venous thromboembolism prevention in children has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thromboembolism

Drugs mentioned

• Dabigatran etexilate (Dabigatran etexilate)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Venous Thromboembolism, Secondary Prevention | Phase 3 | Status: COMPLETED | Results posted: 2020-06-04